Mark Rosenblum, MD

Dr. Mark Rosenblum is the Chairman Emeritus of the Department of Neurosurgery in the Henry Ford Health System, where he expanded the department over 22 years from 4 surgeons to 32 physicians and scientists, had responsibilities for several hospitals, and developed nationally recognized research and clinical excellence.  There he founded and served as a Co-Director of the nationally recognized Hermelin Brain Tumor Center and HFHS Neurosciences Institute.  Mark founded the Michigan Spine Surgery Improvement Collaborative, a statewide quality improvement program with Blue Cross-Blue Shield of Michigan.  He also was one of 4 leaders that developed a new novel, patient-focused Henry Ford West Bloomfield Hospital where he served as Vice President of Clinical Programs and Director of its Center for Health Services Transformation. 

Dr. Rosenblum obtained his Neurosurgery Residency at UCSF where he helped develop its world-leading Brain Tumor Research Center, became Professor, and was continuously funded by the NIH and American Cancer Society for early research on cancer stem cells.  He founded and chaired the Section on Tumors of the American Association of Neurological Surgeons and Congress of Neurological Surgeons, the largest specialty organization of Neuro-Oncology in his field.  He has published 7 books, 240 articles and chapters, trained 63 neurosurgeons and raised $45 Million for the fields in Neuroscience.  He has served on 2 Henry Ford Hospital Boards, its Foundation Board, developed and chaired the Neuroscience Institute Council of Advisors, and served on the Medtronic National Neuroscience Strategic Advisory Board.

In summary, Dr. Rosenblum is a physician, surgeon, researcher, teacher, healthcare administrator and leader with first hand knowledge of health services delivery, innovation and finances.